Abstract:AIM: Adeno-associated virus vector has become the focus as it has good safety, low immunogenicity, could infect separated and unseparated cells as well as mediate stable and long-term expression of exogenous gene. It is the most prospective virus vector for clinical application. In this paper, we observed the effects of recombinant adeno-associated virus vector encoding the report gene of galactosidase LacZ (rAAV-LacZ) transfected bone tissue in vivo. METHODS: The experiment was conducted in the Third Hospital of Peking University Medical School and Yijishan Hospital of Wannan Medical College from January 2005 to January 2006. Eight male SD rats of 8-week old and 220 g were selected and randomly divided into experiment group and control group with 4 in each group. A segmental defect was created in the lateral tibia of four rats in the experiment group, 6×1011 v·g rAAV-LacZ and type Ⅰ collagen sponge composites were implanted into the bone defects, while in the control group, only type Ⅰ collagen sponge composites were implanted. ① After X-gal staining analysis at 6 weeks post-implantation, the gross pathological and histological observation was carried out to detect the β-gal expression. ② The implanted sites, liver and heart tissue mRNA were harvested to detect whether there were specific expressions there by RT-PCR. The same bone defects were created in anther four mature rats and only type Ⅰ collagen sponges were implanted into the bone defects, which served as controls. RESULTS: Eight rats were involved in the result analysis. ① Gross pathological observation showed that the β-gal expressions were found in bone defects and surrounding muscle of the experiment group through X-gal staining, but no marker gene expression was found in the distant tissue (liver and heart) of type Ⅰ collagen sponges implanted defects. ② Histological observation suggested that the β-gal expression was found in the muscle fiber of bone defects in the experiment group without obvious local infiltration in leukomonocytes. In the blue-stained bone cortex, the osteocytes in bone lacuna specifically expressed β-gal, which was not observed in the control group. ③ RT-PCR results appealed that there were specific β-gal expression in the experimental site of the experiment group, while no marker gene expression was found in the distant tissue (liver and heart). There were no gene expression in the experiment site and the distant tissue (liver and heart) of the control group. CONCLUSION: After injected in the bone defects and bone fracture sites, adeno-associated virus vector could effectively transfer the bone and adjacent muscle tissues, and express exogenous gene for at least six weeks; moreover, it is very safe.

The Safety Assessment of Gene Transfer Mediated by the New Recombinant Adeno-Associated Virus Serotype 1 Pseudotyped Vector in Mouse Ischemic Lamb Model

621. Angiogenesis and Arteriogenesis in Ischemic Skeletal Muscles Following VEGF Gene Transfer by Adeno-Associated Virus Serotype 1 Vectors

Superior Neovascularization and Muscle Regeneration in Ischemic Skeletal Muscles Following VEGF Gene Transfer by Raav1 Pseudotyped Vectors

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

Angiogenin Gene Transfer Improves Left Ventricular Function in Rats with Myocardial Infarction

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

Recombinant Adeno-Associated Viral Vector 2-Mediated Gene Transfer of VEGF165 Improved Porcine Chronic Myocardial Ischemia

637. Recombinant Adeno-Associated Viral Vector 2-Mediated Gene Transfer of VEGF Induces Neovascular Formation and Improves Blood Flow in Chronic Ischemic Swine Myocardium

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain.

[Study on Biological Activity of Recombinant Adeno-Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor 165 and Human Bone Morphogenetic Protein 7 Genes in Vitro].

Direct Myocardial Injection of Recombinant Adeno-Associated Viral Vector 2-Mediated VEGF165 Gene Induces Neovas-Cular Formation in Chronic Ischemic Swine Myocardium

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy

Angiopoiesis and Bone Regeneration Via Co-Expression of the Hvegf and Hbmp Genes from an Adeno-Associated Viral Vector in Vitro and in Vivo.

In vivo bone tissue transfection with recombinant adeno-associated virus vector encoding LacZ

Adeno-associated Viral Vector-Mediated Hypoxia-Regulated VEGF Gene Transfer Promotes Angiogenesis Following Focal Cerebral Ischemia in Mice

Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy